Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Cash from Operations (2019 - 2025)

Summit Therapeutics' Cash from Operations history spans 7 years, with the latest figure at 101938000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 109.43% year-over-year to 101938000.0; the TTM value through Dec 2025 reached 322930000.0, down 127.25%, while the annual FY2025 figure was 322930000.0, 127.25% down from the prior year.
  • Cash from Operations reached 101938000.0 in Q4 2025 per SMMT's latest filing, down from 93080000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5191000.0 in Q4 2022 to a low of 101938000.0 in Q4 2025.
  • Average Cash from Operations over 5 years is 32798250.0, with a median of 22117000.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: soared 156.55% in 2022, then crashed 474.86% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 9179000.0 in 2021, then skyrocketed by 156.55% to 5191000.0 in 2022, then plummeted by 474.86% to 19459000.0 in 2023, then tumbled by 150.13% to 48673000.0 in 2024, then plummeted by 109.43% to 101938000.0 in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Cash from Operations are 101938000.0 (Q4 2025), 93080000.0 (Q3 2025), and 66744000.0 (Q2 2025).